✉news HealthHealth first seen 16 h ago, last 9 h ago, peak #16
Drugmakers largely unscathed by Trump drug price plan
Original: Health Brief: Drugmakers unscathed by Trump’s drug price plan
A health brief from The Washington Post reports that pharmaceutical companies have emerged largely unscathed from the Trump administration's drug price plan. The item suggests the plan has had minimal impact on drugmakers so far, contrary to expectations that pricing reforms would hurt the industry.
Why now: Readers are watching how Trump's drug pricing policy affects the pharmaceutical industry.
Trump administrationdrugmakersThe Washington Post
Evidence
- Health Brief: Drugmakers unscathed by Trump’s drug price plan · The Washington Post
API: https://socialmediatrends-api.osmike.com/v1/trends/679840